Neptune reports 31% surge in nutraceutical sales in Q4

29 May 2012

The company said nutraceutical sales rose 31% to $5.36m in the three months to 29 February 2012, while net profits in the division were $1.38m, compared with a net loss of $985,000 for the same period last year.

For the full-year, the company's sales grew by 15% to $19.12m from the $16.5m, with a recorded net loss of $4.59m, compared with a net loss of $1.69m in the same comparable year in 2011.

Neptune president and chief executive Henri Harland said that the management changes that the company announced are in part to put greater emphasis on stimulating sales growth, assessing its business portfolio opportunities and expanding operating profit margins.

Currently, the firm is expanding its facility in Sherbrooke, Québec, to meet the growing demand.

Neptune said the operation of a new factory that will manufacture krill oil products in Asia, is expected to begin by late 2012 or early 2013.

The company develops and commercializes bioactive ingredients and products with clinically proven health benefits, extracting a range of ingredients like omega-3 oils from marine biomass including krill, a deep-water species of crustacean.




Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.